The announcement of a UK government consultation on pharmacist flexibility was met with the kind of anticipation that can only be felt by those who have dedicated their professional lives to seeing their role evolve. It was a chance, finally, to formalise the clinical judgment we exercise every day. I opened the document, eager to read the details, only to be profoundly disappointed.
The proposals—which grant, for example, pharmacists’ statutory discretion to supply a different strength or formulation when the prescribed item is out of stock—inexplicably exclude generic substitution. That core, seemingly uncontroversial, function is deemed out of bounds.
Read more: Community pharmacy: A bespoke future awaits
It is better than nothing, but feels like a small, cautious shuffle in a race we have been running for decades. Buried in the fine print is a further delay: these changes would only come into effect after new legislation for pharmacy technicians to supervise the supply of medicines has been enacted, a process expected to be completed by the end of 2025. That underscores a deeper frustration: pharmacists are being offered not a stride forward, but a grudgingly tolerated baby step.
My immediate gut reaction was, “surely there can be nothing controversial about giving pharmacists such discretion?” I was reminded of my own journey, an “evangelical pharmacist” in a previous life, leaving the dank basements and broom cupboards (that nobody else wanted) of hospital pharmacies to venture onto the wards. I attended the very first lecture when this new notion was introduced to a packed, rapt British audience by a visiting luminary from the USA.
Read more: Seize AI’s benefits, but keep on thinking...
One man who championed this new way of practice was Paul F. Parker, a pioneer from the University of Kentucky; his ground-breaking work with the first hospital-wide unit dose system and a drug information centre in the 1960s had earned him international recognition.
In those days, a British pharmacist had to ask permission of the charge nurse or sister, before entering a ward. The revolution was simple: we would, for example, annotate prescription charts (many of which still used trade names) with the generic names used when supplying those medicines. On one memorable occasion, a local GP in a cottage hospital, today long-closed after a reorganisation, but ripe for reopening for hospice or post-operative care during the next reorganisation, bore down on me.
Read more: Human extinction, pandemics, pharmacy and unicorns
He demanded, “So you’re the **** who has been scribbling all over my charts!”
A vigorous and (at times) collegiate discussion followed. We were fighting for the right to use our professional judgment and knowledge, to move from being mere dispensers to genuine clinical colleagues.
Decades on, the conversation has shifted, but the core frustration remains. We are now in a position where the government, after extensive consultation, is prepared to grant a form of clinical discretion, but has chosen to draw a line at the most basic of substitutions. The reason given is “different patient safety considerations,” but this seems to ring hollow. If we can safely and professionally advise on a different formulation for an out-of-stock item, why is substituting an equivalent generic medicine so hazardous?
Read more: General practitioners and community pharmacists: the forever struggle?
This proposal, therefore, feels less like a vote of confidence and more like an admission of a lack of professional progress. It is a disheartening moment for anyone who remembers the initial evangelism that helped define the clinical pharmacist’s role. It is a journey that began with visionaries like Parker pushing for pharmacists to be on the ward, engaging directly with patient care, and has now led to a consultation that tiptoes around the most common-sense form of dispensing flexibility.
So, whatever your opinion, I urge you to complete the online survey and, maybe, lobby your MP. It may take you five minutes. The word on the street is that such opinions are never actually read by civil servants or political advisers, but they are swayed by how many people are for and against. They might compare the height of the piles, or even their weights, although now, in our age of cyberspace and zero carbon, it all happens digitally. But hopefully, the profound professional disappointment in this limited proposal will leap out.
Dr Malcolm E. Brown is a retired community, hospital and industrial pharmacist, and is a sociologist and honorary careers mentor at the University of East Anglia.